Cargando…
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
Cutaneous T-cell lymphomas (CTCLs) are a subset of T-cell malignancies presenting in the skin. The treatment options for CTCL, in particular in advanced stages, are limited. One of the emerging therapies for CTCL is treatment with histone deacetylase (HDAC) inhibitors. We recently discovered an evol...
Autores principales: | Kwesi-Maliepaard, Eliza Mari, Malik, Muddassir, van Welsem, Tibor, van Doorn, Remco, Vermeer, Maarten H., Vlaming, Hanneke, Jacobs, Heinz, van Leeuwen, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681147/ https://www.ncbi.nlm.nih.gov/pubmed/36425063 http://dx.doi.org/10.3389/fgene.2022.1032958 |
Ejemplares similares
-
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
por: Vlaming, Hanneke, et al.
Publicado: (2019) -
Signals for antigen-independent differentiation of memory CD8(+) T cells
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2021) -
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8(+) T cells
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2020) -
Histone methyltransferase DOT1L controls state‐specific identity during B cell differentiation
por: Aslam, Muhammad Assad, et al.
Publicado: (2021) -
The histone methyltransferase SETD2 negatively regulates cell size
por: Molenaar, Thom M., et al.
Publicado: (2022)